ПАТОФІЗІОЛОГІЧНІ АСПЕКТИ ЛІКУВАННЯ АРТЕРІАЛЬНОЇ ГІПЕРТЕНЗІЇ У ХВОРИХ ВИСОКОГО КАРДІОВАСКУЛЯРНОГО РИЗИКУ
DOI:
https://doi.org/10.30890/2709-2313.2024-26-00-027Ключові слова:
hypertension, obesity, dyslipidaemia, endothelial dysfunction, perindopril, amlodipine, rosuvastatinАнотація
The dynamics of vascular endothelial function, lipid and carbohydrate metabolism in patients with hypertension and abdominal obesity under the influence of 6-month combined antihypertensive (perindopril and amlodipine) and lipid-lowering therapy with atorMetrics
Посилання
Recommendations of the Ukrainian Association of Cardiologists on the Prevention and Treatment of Arterial Hypertension - Kyiv: Business Polygraph, 2008. 80 p.
2003 European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension / European Society of Hypertension-European Society of Cardiology Guidelines Committee // J Hypertens. – 2003. - №21(6). – Р. 1011-1053.
Bertrand M.E. Triple Combination Therapy for Global Cardiovascular Risk: Atorvastatin, Perindopril, and Amlodipine / M.E. Bertrand, C. Vlachopoulos, J.J. Mourad // Am J Cardiovasc Drugs. - 2016. - №16(4). – Р. 241-253.
Blood pressure and cholesterol control in hypertensive hypercholesterolemic patients: national health and nutrition examination / B.M. Egan, J. Li, S. Qanungo [et al.] // Circulation. – 2013. - №128(1). - Р. 29-41.
Comparison between Atorvastatin and Rosuvastatin in Renal Function Decline among Patients with Diabetes / E. Han, G. Kim, J.Y. Lee [et al.] // Endocrinol Metab (Seoul). – 2017. - №32(2). – Р. 274-280.
Comparison of Cost-Effectiveness, Safety, and Efficacy of Rosuvastatin Versus Atorvastatin, Pravastatin, and Simvastatin in Dyslipidemic Diabetic Patients With or Without Metabolic Syndrome / A. Bener, M. Dogan, L. Barakat [et al.] // J. Prim Care Community Health. – 2014. - №11(3). – Р.180-187.
Dalal K.S. Combination cardiovascular drugs / K.S. Dalal, M.B. Bridgeman // Nursing. – 2017. - №47(8). – Р. 70-76.
Effectiveness of a Fixed-Dose, Single-Pill Combination of Perindopril and Amlodipine in Patients with Hypertension: A Non-Interventional Study / S.V. Fleig, B. Weger, H. Haller, F.P. Limbourg // Adv Ther. - 2018 Mar 1. doi: 10.1007/s12325-018-0675-3.
Effectiveness of perindopril/amlodipine fixed dose combination in everyday clinical practice: results from the EMERALD study / C. Vlachopoulos, V. Grammatikou, M. Kallistratos, A. Karagiannis // Curr Med Res Opin. – 2016. - №32(9). – Р. 1605-1610.
Elliott W.J. Perindopril arginine and amlodipine besylate for hypertension: a safety evaluation / W.J. Elliott, E.A. Bistrika // Expert Opin Drug Saf. – 2018. - №17(2). – Р. 207-216.
Endothelial and metabolic effects of perindopril in patients with essential hypertension / A.A. Semenkin, A.I. Novikov, G.I. Nechaeva [et al.] // Kardiologiia. – 2014. - №54(7). – Р. 31-35.
Endothelial cell oxidative stress in diabetes: a key driver of cardiovascular complications? / A. Shaw, M.K. Doherty, N.J. Mutch [et al.] // Biochem. Soc. Trans. – 2014. - №42(4). – Р. 928-933.
Endothelial to mesenchymal transition in the cardiovascular system / H. Gong, X. Lyu, Q. Wang [et al.] // Life Sci. – 2017. - №184. – Р. 95-102.
Engin A. Endothelial Dysfunction in Obesity / A. Engin // Adv Exp Med Biol. – 2017. - №960. – Р. 345-379.
History of vascular reactivity models and their involvement in hypertension pathogenesis / A.G. Conceição-Vertamatti, F. Borghi, F. Canova, D.M. Grassi-Kassisse // Vasa. – 2017. - №46(6). – Р. 431-439.
Hypertension alters the endothelial-dependent biphasic response of bradykinin in isolated Microminipig basilar artery / M. Zahorul Islam, H. Kawaguchi, N. Miura [et al.] // Microvasc Res. – 2017. - №114. – Р. 52-57.
Impact of abdominal obesity and systemic hypertension on risk of coronary heart disease in men and women: the EPIC-Norfolk Population Study / C. Rhеaume, B.J. Arsenault, J.P. Desprеs, [et al.] // J. Hypertens. – 2014. - №6. – Р. 80-106.
Konukoglu D. Endothelial Dysfunction and Hypertension / D. Konukoglu, H. Uzun // Adv Exp Med Biol. – 2017. - №956. – Р. 511-540.
Management of arterial hypertension in adults: 2013 guidelines of the French Society of Arterial Hypertension / J. Blacher, J.M. Halimi, O. Hanon [et al.] // Presse Med. – 2013. - №42(5). - Р.819-825.
Modifications in drug adherence after switch to fixed-dose combination of perindopril/amlodipine in clinical practice. Results of a large-scale Italian experience. The amlodipine-perindopril in real settings (AMPERES) study / Degli L. Esposti, V. Perrone, C. Veronesi [et al.] // Curr Med Res Opin. – 2018. - №22. – Р. 1-7.
Obesity, inflammation and endothelial dysfunction / M. Iantorno, U. Campia, N. Di Daniele [et al.] // J. Biol. Regul. Homeost. Agents. – 2014. - №28(2). – Р. 169-176.
One year persistence of free and fixed dose combinations of perindopril/amlodipine / G. Simonyi, T. Ferenci, M. Medvegy [et al.] // Orv Hetil. – 2017. - №158(36). – Р. 1421-1425.
Oxidative stress and reactive oxygen species in endothelial dysfunction associated with cardiovascular and metabolic diseases / M.A. Incalza, R. D'Oria, A. Natalicchio [et al.] // Vascul Pharmacol. – 2018. - №100. – Р. 1-19.
Podzolkov V.I. Dynamics of Biochemical Markers of Endothelial Dysfunction in Patients With Arterial Hypertension / V.I. Podzolkov, A.I. Tarzimanova // Kardiologiia. – 2016. - №56(8). – Р. 28-32.
Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: Synopsis of the 2017 American College of Cardiology/American Heart Association Hypertension Guideline / R.M. Carey, P.K. Whelton; 2017 ACC/AHA Hypertension Guideline Writing Committee // Ann Intern Med. 2018 Jan 23. doi: 10.7326/M17-3203.
Radermecker R.P. The ASCOT single-pill combination has finally arrived / R.P. Radermecker // Rev Med Liege. – 2017. - №72(9). – Р. 416-422.
Response by Kusters et al to Letter Regarding Article, "Effect of Rosuvastatin on Carotid Intima-Media Thickness in Children With Heterozygous Familial Hypercholesterolemia: The CHARON Study (Hypercholesterolemia in Children and Adolescents Taking Rosuvastatin Open Label)" / D.M. Kusters, M.J. Braamskamp, G. Langslet [et al.] // Circulation. – 2018. - №137(6). – Р. 641-642.
Опубліковано
Як цитувати
Номер
Розділ
Ліцензія
Авторське право (c) 2024 Автори
Ця робота ліцензується відповідно до Creative Commons Attribution 4.0 International License.
